Statistics for Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.

Total visits

views
Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. 70

Total visits per month

views
June 2024 0
July 2024 1
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
Experience_in_Transitioning_From_Parenteral.5.pdf 214